Fibrous dysplasia of the bone. Contribution of Nuclear Medicine in the Diagnosis of Suspicion of Sarcomatous Degeneration;Displasia fibrosa ósea. Aportación de la Medicina Nuclear al diagnóstico de sospecha de degeneración sarcomatosa

Revista Espanola de Medicina Nuclear

Volumn 29, Issue 4, 2010, Pages 172-176

  Santiago Chinchilla, A ^a   Ramos Font, C ^a   Tello Moreno, M ^a   Rebollo Aguirre, A C ^a   Navarro Pelayo Lainez M ^a   Gallego Peinado, M ^a   Llamas Elvira, J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Fibrous dysplasia; Fluorodeoxyglucose positron emission tomography; Malignant transformation; Sarcomatous degeneration

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BONE MALFORMATION; CASE REPORT; DELAYED DIAGNOSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROUS DYSPLASIA; HUMAN; MALIGNANT TRANSFORMATION; NUCLEAR MEDICINE; PATHOLOGIC FRACTURE; POSITRON EMISSION TOMOGRAPHY; SARCOMATOUS DEGENERATION; SYMPTOMATOLOGY;

EID: 77954539598     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/S1578-200X(10)70049-8     Document Type: Article

References (14)

1. DiCaprio M.R., Enneking W.F. Fibrous Dysplasia. Pathophysiology, Evaluation and Treatment. J Bone Joint Surg Am 2005, 87:1848-1864.
2. Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., Jameson J.L., et al. Harrison 16Ed. Principios de Medicina Interna 2005, McGraw-Hill-Interamericana de Mexico, Mexico. D.L. Dennis Kasper, E. Braunwald, A.S. Fauci (Eds.).
3. Berrebi O., Steiner C.H., Keller A., Rougemont A.L., Ratib O. F-18 Fluorodeoxyglucose (FDG) PET in the diagnosis os malignant transformation of Fibrous Dysplasia in the pelvic bones. Clin Nucl Med 2008, 33:469-471.
4. Strobel K., Bode B., Lardinois D., Exner U. PET-positive fibrous dysplasia-a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery. Skeletal Radiol 2007, 36(Suppl1):S24-S28.
5. Stegger L., Juergens K.U., Kliesch S., Wormanns D., Weckesser M. Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT. Eur Radiol 2007, 17:1784-1786.
6. Nakahara T., Fujii H., Hashimoto J., Kubo A. Use of bone SPECT in the evaluation of fibrous dysplasia of the skull. Clin Nucl Med 2004, 29:554-559.
7. Zhibin Y., Quanyong L., Libo C.H., Jun Z., Hankui L., Jifang Z., et al. The role of radionuclide bone scintigraphy in Fibrous Dysplasia of bone. Clin Nucl Med 2004, 29:177-180.
8. Wang K., Allen L., Fung E., Chan C.C., Chan J.C.S., Griffith J.F. Bone scintigraphy in common tumors with osteolytic components. Clin Nucl Med 2005, 30:655-671.
9. Sabatel G., Gómez M., Ortega S., Ramos C., Rodríguez A., López J.M., et al. Displasia ósea en el contexto de un síndrome de McCune-Albright. Rev Esp Med Nucl 2004, 23:202-204.
10. Tembl A., Cordero J.M., Trenor P. Displasia fibrosa en el síndrome de McCune-Albright. Rev Esp Med Nucl 2005, 24:53.
11. Bonkamp D., Jacene H., Bartelt D., Aygun N. Conversion of FDG PET activity of Fibrous Dysplasia of the skull late in life mimicking metastatic disesae. Clin Nucl Med 2008, 33:909-911.
12. Kao C.H., Sun S., Shen Y., Chen Y. Misdiagnosis of multiple bone metastases due to increased FDG uptake in polyostotic Fibrous Dysplasia. Clin Nucl Med 2007, 32:409-410.
13. Shigesawa T., Sugawara Y., Shinohara I., Fujii T., Mochizuki T., Morishige I. Bone metastasis detected by FDG PET in a patient with breast cancer and Fibrous Dysplasia. Clin Nucl Med 2005, 30:571-573.
14. Charest M., Singurkar A., Hickeson M., Novales J.A., Derbekyan V. Intensity of FDG uptake is not everything. Synchronous Liposarcoma and Fibrous Dysplasia in the same patient on FDG PET-CT imaging. Clin Nucl Med 2008, 33:455-458.